-
NBA has no evidence of Clippers salary cap cheating: report
-
Colombian minister under fire over beach holiday post-quake
-
Boehly and Walter consider selling Chelsea stake to Clearlake Capital
-
Lamour leaves key FIFA position after criticising Infantino
-
OpenAI to lease massive new AI data center in US, backed by Nvidia
-
Buss family sells 17.8% stake in Lakers to Iger group
-
US stocks fall on spiking bond yields, higher oil prices
-
Mangione state murder trial postponed after federal guilty plea
-
LIV Golf cancels Michigan event, to decide team title at Indy
-
Trump envoy says Hamas disarmament could begin within 30 days
-
Rodri arrives at Barcelona to complete 'dream' move
-
US pauses construction of border project in Texas national park
-
Discord suspends livestreams in Brazil after teen's suicide
-
Thousands mourn dead black academic in London vigil
-
Tupac Shakur's accused killer was out for 'revenge', jury hears
-
South Africa Test series a lot tougher than a World Cup says All Blacks coach Rennie
-
Netanyahu presses role for US general in Hamas disarmament
-
Coventry sign Nigeria striker Awoniyi from Forest
-
US-Palestinian says 'terrified' as he returns to property besieged by settlers
-
TripleDart tops $7 million ARR with AI-led growth, reports 50 per cent EBIT margin
-
Amboss Opens Affiliate Program: Earn Recurring Bitcoin Commissions by Growing Bitcoin Payments
-
Bipartisan backlash as Trump scales back US-South Korea drills
-
Netanyahu, Kushner discuss US general for Hamas disarmament: Israeli official
-
'Never seen one like it': German pensioners flee wildfire
-
Scottish FA withdraws support for FIFA boss Infantino
-
Ipswich sign Enciso and Ouattara in double raid on Strasbourg
-
Belgium fire halts short of German border, but not 'contained'
-
UN laments 'unacceptable' toll of 350 aid workers killed in 2025
-
Number one Shi suffers shock first-round exit at badminton worlds
-
Former child star actress Hayden Panettiere dead at 36
-
Kolisi and Nche may miss South Africa Test against New Zealand
-
Pakistan captain Babar Azam doubtful for England opener
-
Trump threatens Oman: latest developments in US-Iran war
-
Pentagon inks Tomahawk deal amid reports of missile shortfall
-
Stocks lower as Hormuz concerns and high oil prices persist
-
Rain halts India push after Dinusha century lifts Sri Lanka
-
Crowds turn out for 'Total Eclipse' singer Bonnie Tyler's funeral
-
Dinusha hits century as Sri Lanka post 284 in first India Test
-
Mali jails junta-critic broadcaster, influencer for seven years
-
Stocks steady as investors weigh US rate path
-
'Nowhere to run': Indonesian quake survivors plead for help
-
Taiwan's leader says government to propose record defence spending for 2027
-
Belgium fire makes 'limited' spread overnight, more help on way
-
Cambridge head slams 'feeding frenzy' over dead academic
-
Vingegaard brings curtain down on season
-
Ebola outbreak now DR Congo's deadliest ever
-
Dickwella, Dinusha hit fifties as Sri Lanka fight back
-
Germany's coalition split over putting climate in constitution
-
Bangladesh Test cricket reboot delivers in style with historic win
-
Ukraine badminton star: 'How can you feel normal when bombs are falling?'
Many Laser Specialists Consider the 1927nm Thulium Laser One of the Most Useful Wavelengths Available
ROCKWALL, TX / ACCESS Newswire / June 27, 2026 / Saratoga Technologies, L.L.C., on February 16, 2026, unveiled Laserase™, an FDA-cleared 1927nm Thulium laser system. This platform combines micro-ablative and non-ablative treatments to address pigmentation disorders, photoaging, fine lines, wrinkles, acne scarring, uneven texture, sun damage, melasma, freckles, post-inflammatory hyperpigmentation (PIH), actinic keratosis, enlarged pores, skin laxity, and hair/scalp conditions. It is safe for all Fitzpatrick types (I-VI) with minimal PIH risk.
Laserase™ stimulates collagen remodeling, eliminates recurring consumable costs, and creates micro-channels for deeper absorption of serums, PRP, exosomes, and biologics.
Key Benefits:
Superior pigment correction for melasma, freckles, sun spots, and PIH.
Zero disposables for reduced overhead.
Versatile single platform for broad concerns, including non-surgical lifting and laser-assisted drug delivery.
Safe for ALL SKIN TYPES
Early adopters report 3-5× higher revenue and demand for services like "Thulium Glow".
"Laserase™ elevates practices with transformative results and simplicity, expanding the clinical capabilities of thulium laser technology while remaining accessible and efficient," said Jason Lake, President of Saratoga Technologies, L.L.C. "We designed the platform to help providers deliver consistent outcomes and broaden the services they offer patients."
Laserase™ is now available for demonstration and purchase in the United States, with exclusive previews, priority delivery, and IRS Section 179 eligibility.
About Saratoga Technologies, L.L.C.:
An innovator in aesthetic laser solutions, delivering proven technologies to enhance patient care and practice efficiency nationwide.
Contact Information:

Tom Pallone, C.E.O., Jason Lake, President,
Saratoga Technologies, L.L.C. Saratoga Technologies, L.L.C.
Phone: (888) 263-1113
Website: www.Thulium1927.com or www.Laserase1927.com
Website: https://saratogatec.com/
Media Contact Information
Saratoga Technologies, L.L.C.
[email protected]
SOURCE: Saratoga Technologies, L.L.C.
View the original press release on ACCESS Newswire
H.Gonzales--AT